Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67260775
Modèle: CAS 877399-52-5
marque: DM
Grade Standard: Medicine Grade
Détails d'emballage: Double PE avec sac en aluminium
productivité: 100kg/month
transport: Ocean,Air
Lieu d'origine: Hebei, Chine
Soutenir: 100kg/month
Certificats : ISO9001
Hafen: Shanghai
Type de paiement: L/C,T/T
Incoterm: FOB,CFR,CIF
Name
|
Crizotinib
|
Other Name
|
PF-2341066/Crizotinib
|
CAS No.
|
877399-52-5
|
EINECS
|
N/A
|
MF
|
C21H22Cl2FN5O
|
MW
|
450.343
|
Purity
|
99% min
|
Usage
|
Crizotinib is a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic
lymphoma kinase (ALK). Crizotinib is a potential antitumor agent. |
Appearance
|
White Solid
|
Le crizotinib est un médicament anticancéreux agissant comme un inhibiteur alk (lymphome anaplasique kinase) et ROS1 (C-Ros oncogène 1), approuvé pour le traitement de certains carcinomes pulmonaires non à petites cellules (NSCLC) aux États-Unis et dans certains autres pays, et En subir des essais cliniques testant sa sécurité et son efficacité dans le lymphome anaplasique à grande cellule, le neuroblastome et d'autres tumeurs solides avancées chez les adultes et les enfants.
Groupes de Produits : API et intermédiaires > Intermédiaires du crizotinib
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.